TABLE 2.
Peptide | Mutated residue | Phase 1 (FLS2-Flg22) |
Phase 2 (FLS2/Flg22-BAK1) |
||
---|---|---|---|---|---|
ΔΔGbind (kcal mol−1) | Deleteriousa | ΔΔGbind (kcal mol−1) | Deleteriousa | ||
Flg22-2 | Q1E | 1.38 | No | −0.44 | No |
T5S | 0.72 | No | −0.65 | No | |
S7L | −0.13 | No | −1.17 | No | |
R8K | 1.37 | No | −0.36 | No | |
K13S | 2.22 | Yes | –0.3 | No | |
L19Q | 1.37 | No | 1.52 | Yes | |
Q20A | 2.09 | Yes | −0.06 | No |
Deleterious (yes/no): the MutaBind2 server uses ΔΔG ≥ 1.5 or ≤−1.5 kcal mol−1 to define whether or not a mutation is deleterious. ΔΔG ≥ 1.5 kcal mol−1 is deleterious.